mRNA |
BRD8899 |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.5 |
mRNA |
KU-0063794 |
CTRPv2 |
pan-cancer |
AAC |
0.025 |
0.5 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.5 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.5 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.5 |
mRNA |
LAQ824 |
GDSC1000 |
pan-cancer |
AAC |
-0.022 |
0.5 |
mRNA |
apicidin |
CTRPv2 |
pan-cancer |
AAC |
0.022 |
0.5 |
mRNA |
VAF-347 |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.5 |
mRNA |
BRD-K09587429 |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.5 |
mRNA |
ifosfamide |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.5 |